Electrogram Guided Myocardial Advanced Phenotyping (EMAP) Study for patients recently diagnosed with cardiomyopathy

Site Image

Study Overview

This study is enrolling newly diagnosed heart failure (within 6 months from diagnosis) patients with no known cause for their heart disease. We are utilizing already used technology, voltage mapping capabilities used in electrophysiology procedures, to more directly target weaker areas of the left and right ventricles. our physicians would biopsy the places the mapping technology guides us, and our goal is to understand the potential benefit in yield of this technique.

Study Description

patients will undergo a clinically indicated biopsy, and during this procedure we would biopsy the patient's heart tissue the standard way as well as the voltage mapping pathway. study subjects would get a clinical read from some of the tissue samples, and some will be banked for later analysis. We will follow patients clinically at three months for outcomes. 

Additional Information:

please contact Todd Nicklas at 215-662-4214 for more information. 

  • Study Identifier: 826102

Recruitment Status


Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Sign-up

Participate in medical studies to develop new diagnostic and clinical treatments and improve current standards of care.

Sign Up Now!

If you need assistance finding a non-cancer study or if you have any questions, please email psom-ocr@pobox.upenn.edu